Bradmer Pharmaceuticals Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 1

Bradmer Pharmaceuticals General Information

Description

Provider of pharmaceutical products. The company's product line specializes in the development and commercialization of new and innovative cancer therapies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 365 Bay Street
  • Suite 800
  • Toronto, Ontario M5H 2V1
  • Canada
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 365 Bay Street
  • Suite 800
  • Toronto, Ontario M5H 2V1
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bradmer Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bradmer Pharmaceuticals‘s full profile, request access.

Request a free trial

Bradmer Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bradmer Pharmaceuticals‘s full profile, request access.

Request a free trial

Bradmer Pharmaceuticals Acquisitions (1)

Bradmer Pharmaceuticals’s most recent deal was a Reverse Merger with First Coin Capital. The deal was made on 10-Oct-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
First Coin Capital 10-Oct-2017 Reverse Merger Other Financial Services
To view Bradmer Pharmaceuticals’s complete acquisitions history, request access »

Bradmer Pharmaceuticals FAQs

  • When was Bradmer Pharmaceuticals founded?

    Bradmer Pharmaceuticals was founded in 2005.

  • Where is Bradmer Pharmaceuticals headquartered?

    Bradmer Pharmaceuticals is headquartered in Toronto, Canada.

  • What industry is Bradmer Pharmaceuticals in?

    Bradmer Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Bradmer Pharmaceuticals a private or public company?

    Bradmer Pharmaceuticals is a Private company.

  • What is Bradmer Pharmaceuticals’s current revenue?

    The current revenue for Bradmer Pharmaceuticals is .

  • How much funding has Bradmer Pharmaceuticals raised over time?

    Bradmer Pharmaceuticals has raised $424K.

  • Who are Bradmer Pharmaceuticals’s investors?

    Evermore Investments has invested in Bradmer Pharmaceuticals.

  • When was Bradmer Pharmaceuticals acquired?

    Bradmer Pharmaceuticals was acquired on 31-Jul-2018.

  • Who acquired Bradmer Pharmaceuticals?

    Bradmer Pharmaceuticals was acquired by First Coin Capital.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process